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Exercise-induced bronchoconstriction (EIB) 
is a subtype of asthma with a prevalence of 
90% in asthmatics and prevalences ranging 
from 10 to 50% in the elite athlete popula-
tion [1–3]. Research indicates that asthma 
and/or EIB prevalence is high in male chil-
dren and adolescents. In adults however, a 
switch occurs, with female rates dominat-
ing [4]. Adult females also report higher 
asthma exacerbations and hospitalizations [5]. 
Among athletes, females also outnumber 
their male counterparts with regards to pres-
ence of EIB, although the underlying mecha-
nisms have not been elucidated [3,6]. This edi-
torial aims to present the current state of the 
literature and signpost future directions of 
sex-based differences in athletic populations.
Particularly common in cold-weather ath-
letes, EIB occurs due to repetitive breathing 
of dry air at high ventilation and exposure 
to environmental agents such as pollen, chlo-
rinated compounds in swimming pools (in 
swimmers) and irritant agents from ice rinks.
The underlying mechanisms include an 
initial attempt of the airways to humidify the 
large volume of inspired air, causing evapora-
tive water loss and a temperature drop at the 
airway surface, followed by development of 
a hyperosmolar environment. This in turn 
leads to the release of reactive mediators, 
such as histamine. In parallel to these cellular 
consequences, the cooling and quick rewarm-
ing of the airway surface induces a mechani-
cal effect including edema and engorgement 
of the bronchial vasculature [7]. In an other-
wise inflammatory environment, subsequent 
mucus overproduction, cough and pres-
ence of other typical asthma symptoms pre-
vail, along with the worst and perhaps most 
critical symptom: airway narrowing [8].
Exercise has thus become a contradictory 
term for asthma researchers, in that it clearly 
improves cardiopulmonary fitness without 
much effect on lung function [9], and simulta-
neously lowers quality-of-life, particularly for 
highly trained athletes. Furthermore, it is evi-
dent from statistics highlighting asthma deaths 
in sports that white 10- to 20-year-old males 
with mild intermittent or persistent asthma are 
a particularly vulnerable group [10]. Asthma 
deaths occur in female subjects too, but to a 
lower extent. This could allude to female biol-
ogy incurring a protective effect, although no 
theories have been proposed to support this. It 
is therefore more probable that higher preva-
lence rates linked to lower participation rates 
may be masking a potential increased risk 
for females participating in sports. This issue 
needs to be explored in more detail.
Perhaps, it is stating the obvious that there 
is a need to study male and female athletes 
and asthma/EIB association as so many 
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physiological changes (height, weight, etc.) occur with 
transition into adulthood, thus impacting lung func-
tion. In other chronic diseases, there is evidence of the 
importance of female biology. As an example, female 
hormones clearly play a role in risk association with 
cardio vascular disease while polycystic ovarian syn-
drome has been shown to serve as a predictor for both 
cardiovascular disease and diabetes [11]. Although the 
wider research community has realized the need to focus 
on female participants/athletes [12], data are still scarce 
in relation to asthma and athletes with EIB.
One noteworthy association has been proposed 
between EIB and the development of exercise-induced 
arterial hypoxemia in females. The bronchospasm 
occurring in EIB causes increase in airway resistance, 
which in turn has the potential to alter the ventilation-
perfusion ratio of the lung resulting in a drop of partial 
pressure of oxygen content in arteries. The study high-
lighting this association showed that 23% of female ice 
hockey players exhibited EIB and 76% also presented 
with exercise-induced arterial hypoxemia, at their 
maximal level of exercise intensity [13]. Studies such 
as these are promising as the information arising from 
these will eventually allow for biological mechanisms 
to be explained in detail.
Furthermore, the menstrual cycle has been shown 
to exert notable effects in female athletes. A study con-
ducted on female athletes [14] encompassing the expres-
sion of over a 100 inflammatory genes after aerobic 
exercise, highlight a marked proinflammatory gene 
upregulation during the follicular phase (menstrual 
cycle day 10) of these women accompanied by an 
anti-inflammatory gene downregulation during their 
luteal phase (day 25), in comparison with a group of 
male subjects serving as controls. However, the subse-
quent protein expression profile associated with these 
findings at gene level is not yet fully elucidated.
Moreover, estrogen is thought to exhibit both pro- 
and anti-inflammatory effects, mostly demonstrated 
by in vitro findings. Notably, estrogen receptors are 
thought to be expressed on both smooth muscle and 
vascular endothelial cells, thus suggesting a possible 
link between hormonal regulation and development of 
asthma and airway hyper-responsiveness/EIB [15].
Lung function and EIB symptoms are also sig-
nificantly worse in female athletes during mid-luteal 
phase when salivary progesterone levels are at peak, 
compared with mid-follicular menstrual cycle phase 
when salivary progesterone levels are lower [16].
There are several challenges posed when including 
female participants in research studies, including the 
need to conform to menstrual cycle changes over the 
course of the month encompassing intersubject differ-
ences in fertility phase: menopausal age and absence of 
puberty (children), and of course the absence or disrup-
tion of menstrual cycle in female athletes along with the 
use of oral contraceptives. All these factors are known to 
influence immunological and physiological functions in 
females. These challenges may be overcome by designing 
small cohorts, as studies on athletes typically involve low 
number of participants. Northoff’s study on gene expres-
sion involved 9 females and 12 males: a relatively small 
cohort compared with other gene expression studies. 
Some researchers may disagree with this [12], and instead 
suggest studies involving female subjects should be 
larger in order to account for intersubject differences in 
hormone profiles and to provide sufficient study power.
To conclude, there is increasing evidence of female 
athletes exhibiting more severe EIB/asthma, particu-
larly during the latter part of their menstrual cycle. 
To date however, there is no consensus within the lit-
erature that fully elucidates the underpinning mecha-
nisms of sex-based differences in EIB prevalence and 
severity. To some extent, there is also limited accep-
tance that this issue needs to be interrogated further. 
The future may allow for females to gain greater con-
trol of their respiratory health through knowledge of 
their hormones and their effects thereof. This knowl-
edge has further potential to expand into the wider 
research community, thus allowing athletic profes-
sionals to study performance effects and medical 
researchers to develop novel therapeutic targets based 
on male and female biology and their respective dif-
ferences. The time is therefore now to call for more 
research into this fascinating subject area.
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“…there is no consensus within the literature that 
fully elucidates the underpinning mechanisms 
of sex-based differences in exercise-induced 
bronchoconstriction prevalence and severity.”
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